This content is only available within our institutional offering.

07 Sep 2017
PANMURE: Raising target price as Faron enters value enhancing period

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
PANMURE: Raising target price as Faron enters value enhancing period
Faron Pharmaceuticals Oy (FARN:LON) | 175 0 0.0% | Mkt Cap: 198.5m
- Published:
07 Sep 2017 -
Author:
Julie Simmonds -
Pages:
7 -